These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 10485716

  • 1. Aldosterone antagonism in heart failure.
    Richards AM, Nicholls MG.
    Lancet; 1999 Sep 04; 354(9181):789-90. PubMed ID: 10485716
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct 21; 146(43):58-9. PubMed ID: 15559524
    [No Abstract] [Full Text] [Related]

  • 3. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec 02; 152(48):12-3. PubMed ID: 21226226
    [No Abstract] [Full Text] [Related]

  • 4. [Aldosterone and its antagonists in heart failure].
    Lopes ME, Le Corvoisier P, Tabet JY, Su JB, Badoual T, Cachin JC, Merlet P, Castaigne A, Hittinger L.
    Presse Med; 2003 Jan 18; 32(2):79-87. PubMed ID: 12653034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
    Orea-Tejeda A, Colín-Ramírez E, Castillo-Martínez L, Asensio-Lafuente E, Corzo-León D, González-Toledo R, Rebollar-González V, Narváez-David R, Dorantes-García J.
    Rev Invest Clin; 2007 Jan 18; 59(2):103-7. PubMed ID: 17633796
    [Abstract] [Full Text] [Related]

  • 7. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul 07; 147(27-28):44. PubMed ID: 16041942
    [No Abstract] [Full Text] [Related]

  • 8. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
    Aaronson K.
    Health News; 2003 May 07; 9(5):4. PubMed ID: 12739453
    [No Abstract] [Full Text] [Related]

  • 9. Beta-blockers and spironolactone in heart failure.
    Kukin ML.
    Curr Cardiol Rep; 2000 Mar 07; 2(2):87-9. PubMed ID: 10980877
    [Abstract] [Full Text] [Related]

  • 10. [Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
    Azpitarte Almagro J.
    Med Clin (Barc); 2000 Apr 15; 114(14):545-50. PubMed ID: 10846668
    [No Abstract] [Full Text] [Related]

  • 11. [Aldosterone antagonists for all patients with heart failure?].
    Bauersachs J.
    MMW Fortschr Med; 2009 Apr 09; 151(15):33-5. PubMed ID: 19728679
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?
    Struthers AD.
    Br J Clin Pharmacol; 1999 May 09; 47(5):479-82. PubMed ID: 10336570
    [No Abstract] [Full Text] [Related]

  • 15. Hyperkalaemia in the age of aldosterone antagonism.
    Chapagain A, Ashman N.
    QJM; 2012 Nov 09; 105(11):1049-57. PubMed ID: 22723454
    [Abstract] [Full Text] [Related]

  • 16. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
    Mundhenke M.
    Dtsch Med Wochenschr; 2006 Oct 13; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
    [No Abstract] [Full Text] [Related]

  • 17. Aldosterone receptor antagonists for heart failure: current status, future indications.
    Pitt B, Rajagopalan S.
    Cleve Clin J Med; 2006 Mar 13; 73(3):257-60, 264-8. PubMed ID: 16548448
    [Abstract] [Full Text] [Related]

  • 18. The year in cardiology: heart failure 2014.
    Voors AA, Ruschitzka F.
    Eur Heart J; 2015 Feb 14; 36(7):421-4. PubMed ID: 25575601
    [No Abstract] [Full Text] [Related]

  • 19. [Decrease in mortality on spironolactone being added to the conventional treatment of heart failure].
    Soto Alvarez J.
    Aten Primaria; 2000 Mar 15; 25(4):282-4. PubMed ID: 10795447
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E.
    Internist (Berl); 2005 Apr 15; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.